In this Issue:
Continuous vs interrupted adalimumab or etanercept
NAFLD and NASH among patients with psoriasis
Calcipotriol + betamethasone for adolescent scalp psoriasis
Long-term safety and efficacy of brodalumab
Interleukin-19 in psoriasis
Long-term safety and efficacy of ixekizumab
Fumaderm® in daily practice for psoriasis
Acute severe methotrexate toxicity
Childhood and adolescent psoriasis in Greece
Biologicals in combination with other therapies
Please login below to download this issue (PDF)